# Shai Levy

> Shai Levy is a seed investor at ProSeed Venture Capital Fund (Tel Aviv) backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ProSeed Venture Capital Fund](https://shizune.co/investors/profile/proseed-venture-capital-fund)
- Location: Tel Aviv, Israel
- Total investments: 2
- Last investment: Mar 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/shailevy1/

Shai Levy is a seed investor at ProSeed Venture Capital Fund in Tel Aviv focused on Biotechnology. Mr. Shai Levy has been the CEO of ProSeed Venture Capital Fund Ltd (traded on the Tel Aviv Stock Exchange as TLV:PRSD) since 2012. Mr. Levy has a key role in managing ProSeed fund's investments, deal flow, financing and M&A as well as serving on a variety of companies Board of Directors in a wide range of industries.Mr. Levy gainedbroad-based management experience with investments in the U.S, Europe and Israel in various sectors mostly focusing on High-Tech, Real Estate and Family Office.Prior to Joining ProSeed, Mr. Levy served as the Chief Financial & Investment Officer for the Tahari Family in New York for over 5 years, as Director of Financial Reporting & Compliance at the Deutsch Inc, New York (a part of Interpublic Group NYSE:IPG), auditor at PwC, New York and at Ernst and Young Israel.Mr. Levy holds a Bachelor's degree in Accounting and Finance from Tel-Aviv University and is a Certified Public Accountant (CPA) in Israel.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brevel | Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed. | $5M | Seed | Mar 23, 2025 |  |
| Brevel | Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed. | $10.1M | Seed | Jul 25, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [EIC Accelerator](https://shizune.co/investors/profile/eic-accelerator) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/eic-fund) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together
- [European Innovation Council Fund](https://shizune.co/investors/profile/european-innovation-council-fund) — VC Fund, 1 deal together
- [Good Protein](https://shizune.co/investors/profile/good-protein) — VC Fund, 1 deal together
- [PVS Investments](https://shizune.co/investors/profile/pvs-investments) — VC Fund, 1 deal together

## About ProSeed Venture Capital Fund

VC Fund · Tel Aviv, Israel

ProSeed, an established Israeli Venture Capital firm since April 2000, provides funding as well as hands-on managerial assistance and analytical support to capable technology-based enterprises.ProSeed specializes in funding companies that require early stage financial support. ProSeed, together with the Technion Research and DevelopmentFoundation (TRDF), played a central role in initiating and establishing the Technion Incubator, with major venture capital firms including, Vertex, Vitalife and Battery along with the Technion-Israel Institute of Technology.

3 contacts available at ProSeed Venture Capital Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Shai Levy | CEO | https://shizune.co/investors/profile/shai-levy |
| Adina Makover | Life Science Director | https://shizune.co/investors/profile/dr-adina-makover |
| Yigal Landau | Director | https://shizune.co/investors/profile/yigal-landau |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Shai Levy invest in?

Shai Levy invests primarily in Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shai Levy last invest?

The most recent investment recorded for Shai Levy closed in Mar 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co